Access Intelligence (ACCI.L): Corp Half-year trading update | Avacta (AVTG.L): Corp Potential COVID-19 therapeutic – progress | Synairgen (SNG): Corp COVID-19 home setting trial amendments | Tremor (TRMR): Corp Strong Q1 before large COVID-19 impacts in Q2
18 Jun 2020
Morning Note – 18 June 2020
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note – 18 June 2020
Synairgen plc (SNG:LON), 6.7 | Nexxen International Ltd. (NEXN:LON), 229 | Access Intelligence Plc (ACC:LON), 53.0
- Published:
18 Jun 2020 -
Author:
Andrew Darley | Mark Brewer | Michael Hill | Cavendish Research -
Pages:
7
Access Intelligence (ACCI.L): Corp Half-year trading update | Avacta (AVTG.L): Corp Potential COVID-19 therapeutic – progress | Synairgen (SNG): Corp COVID-19 home setting trial amendments | Tremor (TRMR): Corp Strong Q1 before large COVID-19 impacts in Q2